ATS GUIDELINES Bundle

Idiopathic Pulmonary Fibrosis Diagnosis

American Thoracic Society Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1101466

Contents of this Issue

Navigation

Page 12 of 13

13 Abbreviations ALAT, Latin American oracic Society; ATS, American oracic Society; CCL-18, chemokine ligand 18; CT, computed tomography; CTD, connective tissue disease; dx, diagnosis; ERS, European Respiratory Society; GGO, ground-glass opacities; HRCT, high-resolution computed tomography; IIP, idiopathic interstitial pneumonia; ILD, interstitial lung disease; IPF, idiopathic pulmonary fibrosis; JRS, Japanese Respiratory Society; KL-6, Krebs von den Lungen-6; LAM, lymphangioleiomyomatosis; MDD, multidisciplinary discussion; MMP-7, matrix metalloproteinase 7; RA, rheumatoid arthritis; SPD, surfactant protein D; UIP, usual interstitial pneumonia Grading of Recommendations, Assessment, Development, and Evaluation (GRADE)-Based Recommendations Implications for: Strong Recommendation (S) Conditional Recommendation (C) Patients e overwhelming majority of individuals in this situation would want the recommended course of action and only a small minority would not. e majority of individuals in this situation would want the suggested course of action, but a sizeable minority would not. Clinicians e overwhelming majority of individuals should receive the recommended course of action. Adherence to this recommendation according to the guideline could be used as a quality criterion or performance indicator. Formal decision aids are not likely to be needed to help individuals make decisions consistent with their values and preferences. Different choices will be appropriate for different patients, and you must help each patient arrive at a management decision consistent with her or his values and preferences. Decision aids may be useful to help individuals make decisions consistent with their values and preferences. Policy Makers e recommendation can be adapted as policy in most situations, including for use as performance indicators. Policy making will require substantial debates and involvement of many stakeholders. Policies are also more likely to vary between regions. Performance indicators would have to focus on the fact that adequate deliberation about the management options has taken place. Certainty in the Evidence High H Low L Moderate M Very Low VL

Articles in this issue

view archives of ATS GUIDELINES Bundle - Idiopathic Pulmonary Fibrosis Diagnosis